{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,21]],"date-time":"2023-10-21T16:55:24Z","timestamp":1697907324812},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[1981,1,1]],"date-time":"1981-01-01T00:00:00Z","timestamp":347155200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[1981]]},"DOI":"10.1007\/bf00568397","type":"journal-article","created":{"date-parts":[[2004,11,20]],"date-time":"2004-11-20T15:29:23Z","timestamp":1100964563000},"page":"113-118","source":"Crossref","is-referenced-by-count":5,"title":["A clinical and pharmacokinetic evaluation of tolmesoxide in hypertensive patients"],"prefix":"10.1007","volume":"19","author":[{"given":"J. H.","family":"Silas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F. C.","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Freestone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. T.","family":"Tucker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L. E.","family":"Ramsay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","unstructured":"Buylla JA, Clifford JM, Wynne RD (1979) The action of tolmesoxide on certain cardiovascular measurements in healthy human volunteers. Br J Clin Pharmacol 8: 402P","DOI":"10.1111\/j.1365-2125.1979.tb04749.x"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1365-2125.1978.tb01595.x","volume":"5","author":"JG Collier","year":"1978","unstructured":"Collier JG, Lorge RE, Robinson BF (1978) Comparison of effects of tolmesoxide (RX 71107), diazoxide, hydralazine, prazosin, glyceryl trinitrate and sodium nitroprusside on forearm arteries and dorsal hand veins of man. Br J Clin Pharmacol 5: 35?44","journal-title":"Br J Clin Pharmacol"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1476-5381.1978.tb07780.x","volume":"63","author":"JC Doxey","year":"1978","unstructured":"Doxey JC (1978) Tolmesoxide, a drug that lowers blood pressure by a direct relaxant effect on vascular smooth muscle. Br J Pharmacol 63: 111?118","journal-title":"Br J Pharmacol"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1161\/01.CIR.45.3.571","volume":"45","author":"TB Gottlieb","year":"1972","unstructured":"Gottlieb TB, Katz FH, Chidsey CA (1972) Combined therapy with vasodilator drugs and ? adrenergic blockade in hypertension. Circulation 45: 571?582","journal-title":"Circulation"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1056\/NEJM197604222941706","volume":"284","author":"OB Holland","year":"1976","unstructured":"Holland OB, Kaplan NM (1976) Propranolol in the treatment of hypertension. N Engl J Med 284: 930?936","journal-title":"N Engl J Med"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1042\/cs051579s","volume":"51","author":"RG Jacomb","year":"1976","unstructured":"Jacomb RG, Brunnberg FJ (1976) The use of minoxidil in the treatment of severe essential hypertension: A report on 100 patients. Clin Sci 51: 579?581","journal-title":"Clin Sci"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0002-8703(78)90391-5","volume":"95","author":"J Koch-Weser","year":"1978","unstructured":"Koch-Weser J (1978) The comeback of hydralazine. Am Heart J 95: 1?3","journal-title":"Am Heart J"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/BF00568398","volume":"19","author":"JG Lloyd-Jones","year":"1981","unstructured":"Lloyd-Jones JG, Henson RA, Nichols JD, Greenslade D, Clifford JM (1981) Pharmacokinetics of intravenous and oral telmesoxide. Eur J Clin Pharmacol 19: 119?125","journal-title":"Eur J Clin Pharmacol"},{"key":"CR9","first-page":"283","volume":"32","author":"OL Pederson","year":"1977","unstructured":"Pederson OL (1977) Long-term experiments with minoxidil in combination treatment of severe arterial hypertension. Acta Cardiol 32: 283?293","journal-title":"Acta Cardiol"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/0002-9343(73)90084-3","volume":"54","author":"HM Perry","year":"1973","unstructured":"Perry HM (1973) Late toxicity to hydralazine resembling systemic lupus erythematosis or rheumatoid arthritis. Am J Med 54: 58?72","journal-title":"Am J Med"},{"key":"CR11","unstructured":"Reckitt & Colman: Data on File"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1056\/NEJM197508072930606","volume":"293","author":"DG Shand","year":"1975","unstructured":"Shand DG (1975) Propranolol. N Engl J Med 293: 280?285","journal-title":"N Engl J Med"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1136\/hrt.43.2.202","volume":"43","author":"JH Silas","year":"1980","unstructured":"Silas JH, Barker AT, Ramsay LE (1980) A clinical evaluation of the Dinamap 845 automated blood pressure recorder. Br Heart J 43: 202?205","journal-title":"Br Heart J"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1001\/jama.1977.03270480043018","volume":"237","author":"Veterans Administration Co-operative Study Group on Antihypertensive agents","year":"1977","unstructured":"Veterans Administration Co-operative Study Group on Antihypertensive agents (1977) Propranolol in the treatment of essential hypertension. J Am Med Assoc 237: 2303?2310","journal-title":"J Am Med Assoc"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1136\/bmj.2.6086.547","volume":"2","author":"RG Wilcox","year":"1977","unstructured":"Wilcox RG, Mitchell JRA (1977) Contribution of atenolol, bendrofluazide and hydralazine to management of severe hypertension. Br Med J 2: 547?550","journal-title":"Br Med J"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00568397.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00568397\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00568397","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,4]],"date-time":"2019-04-04T23:18:06Z","timestamp":1554419886000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00568397"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1981]]},"references-count":15,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1981]]}},"alternative-id":["BF00568397"],"URL":"https:\/\/doi.org\/10.1007\/bf00568397","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[1981]]}}}